ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 61 filers reported holding ONCOCYTE CORP in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $11,541,707 | +39.5% | 50,181,335 | +114.9% | 0.86% | +48.3% |
Q1 2023 | $8,276,550 | +10.4% | 23,353,697 | 0.0% | 0.58% | -7.2% |
Q4 2022 | $7,494,201 | -56.0% | 23,353,697 | 0.0% | 0.63% | -51.8% |
Q3 2022 | $17,048,000 | -18.9% | 23,353,697 | 0.0% | 1.30% | -17.9% |
Q2 2022 | $21,011,000 | -18.7% | 23,353,697 | +34.6% | 1.58% | -15.0% |
Q1 2022 | $25,851,000 | -31.3% | 17,349,945 | 0.0% | 1.86% | -19.4% |
Q4 2021 | $37,649,000 | -39.0% | 17,349,945 | 0.0% | 2.31% | -26.6% |
Q3 2021 | $61,766,000 | -35.9% | 17,349,945 | +3.4% | 3.15% | -26.8% |
Q2 2021 | $96,297,000 | +10.6% | 16,776,484 | 0.0% | 4.30% | -7.0% |
Q1 2021 | $87,070,000 | +147.6% | 16,776,484 | +14.0% | 4.63% | +121.9% |
Q4 2020 | $35,172,000 | +71.9% | 14,716,204 | 0.0% | 2.09% | +29.6% |
Q3 2020 | $20,456,000 | -27.2% | 14,716,204 | 0.0% | 1.61% | -26.8% |
Q2 2020 | $28,108,000 | -16.1% | 14,716,204 | +7.7% | 2.20% | -43.9% |
Q1 2020 | $33,482,000 | +21.2% | 13,666,204 | +11.3% | 3.91% | +22.9% |
Q4 2019 | $27,618,000 | +18.5% | 12,274,738 | +10.6% | 3.18% | -1.5% |
Q3 2019 | $23,306,000 | +15.6% | 11,098,267 | +37.0% | 3.24% | +28.3% |
Q2 2019 | $20,165,000 | -37.0% | 8,098,267 | 0.0% | 2.52% | -35.6% |
Q1 2019 | $31,988,000 | +206.4% | 8,098,267 | +7.1% | 3.92% | +167.4% |
Q4 2018 | $10,440,000 | -44.8% | 7,564,934 | 0.0% | 1.46% | -16.6% |
Q3 2018 | $18,912,000 | -2.0% | 7,564,934 | 0.0% | 1.76% | -20.7% |
Q2 2018 | $19,291,000 | +21.4% | 7,564,934 | 0.0% | 2.22% | -4.0% |
Q1 2018 | $15,886,000 | -5.0% | 7,564,934 | +110.3% | 2.31% | -1.0% |
Q4 2017 | $16,725,000 | -38.4% | 3,596,680 | 0.0% | 2.33% | -48.2% |
Q3 2017 | $27,155,000 | +70.8% | 3,596,680 | +17.7% | 4.50% | +53.9% |
Q2 2017 | $15,895,000 | -12.6% | 3,056,680 | 0.0% | 2.92% | -15.7% |
Q1 2017 | $18,187,000 | -2.0% | 3,056,680 | +16.1% | 3.47% | +10.3% |
Q4 2016 | $18,553,000 | +39.9% | 2,631,680 | 0.0% | 3.14% | +38.5% |
Q3 2016 | $13,264,000 | +240.8% | 2,631,680 | +140.7% | 2.27% | +201.9% |
Q2 2016 | $3,892,000 | -22.8% | 1,093,219 | 0.0% | 0.75% | -28.0% |
Q1 2016 | $5,040,000 | -26.2% | 1,093,219 | 0.0% | 1.04% | -9.3% |
Q4 2015 | $6,833,000 | – | 1,093,219 | – | 1.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AWM Investment Company, Inc. | 719,282 | $2,359,245 | 0.35% |
Defender Capital, LLC. | 114,520 | $357,302 | 0.13% |